Copyright
©2014 Baishideng Publishing Group Inc.
World J Stem Cells. Jul 26, 2014; 6(3): 355-366
Published online Jul 26, 2014. doi: 10.4252/wjsc.v6.i3.355
Published online Jul 26, 2014. doi: 10.4252/wjsc.v6.i3.355
Table 1 Effect of peripheral arterial disease on endothelial progenitor cells
| Ref. | Subjects | EPCs (number/function) | Findings |
| Fadini et al[14] | 55 diabetic without PAD 72 diabetic with PAD | CD34+/CD133+/KDR+ | CD34+/CD133+/KDR+ is significantly lower in diabetics with PAD compared to diabetics alone |
| Fadini et al[15] | 15 healthy controls 30 PAD | CD34+/KDR+ | CD34+/KDR+ is significantly lower in patients with PAD than controls |
| Delva et al[17] | 24 healthy controls 45 PAD | CFU CD133+, CD34+, CD34+/KDR+ | CFU is significantly increased in patients with PAD compared to controls CD34+ and CD133+ are significantly decreased in patients with PAD compared to controls No difference between groups for CD34+/KDR+ |
| Morishita et al[16] | 22 healthy controls 48 PAD | CD34+/CD133+/ KDR+ | CD34+/CD133+/KDR+ is significantly higher in PAD compared to controls |
- Citation: Lee PSS, Poh KK. Endothelial progenitor cells in cardiovascular diseases. World J Stem Cells 2014; 6(3): 355-366
- URL: https://www.wjgnet.com/1948-0210/full/v6/i3/355.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v6.i3.355